Abstract
The issue of pharmacoresistance in epilepsy has received considerable attention in recent years, and a number of plausible hypotheses have been proposed. Of these, the so-called transporter hypothesis is the most extensively researched and documented. This hypothesis assumes that refractory epilepsy is associated with a localised over-expression of drug transporter proteins such as P-glycoprotein (Pgp) in the region of the epileptic focus, which actively extrudes antiepileptic drugs (AEDs) from their intended site of action. However, although this hypothesis has biological plausibility, there is no clinical evidence to support the assertion that AEDs are sufficiently strong substrates for transportermediated extrusion from the brain. The use of modern brain imaging techniques to determine Pgp function in patients with refractory epilepsy has started only recently, and may ultimately determine whether increased expression and function of Pgp or other efflux transporters are involved in AED resistance.
Keywords: Multidrug transporters, antiepileptic drugs, brain imaging, positron emission tomography, verapamil, tariquidar, P-glycoprotein, Epilepsy, Antiepileptic drugs (AEDs), Erapamil, blood-brain barrier (BBB), CNS disorder, Temporal lobe epilepsy (TLE), Pgp expression, Single photon emission computed tomography (SPECT), Magnetic resonance spectroscopy (MRS), Radiotracers, Pgp substrates, [11C]daunorubicin, [11C]colchicine, [18F]paclitaxel, [11C]carvedilol, [11C]loperamide, [11C]-Ndesmethyl-loperamide, cyclosporin A (CsA), (R)-enantiomer, (S)-enantiomer, Cytochrome P450-mediated metabolism, Pgp function, liquid chromatography tandem mass spectrometry (LC/MS/MS), Chinese hamster ovary resistant cells (CHrB30), [99mTc]sestamibi, Single nucleotide polymorphism (SNP), [11C]phenobarbital, [11C]phenytoin
Current Topics in Medicinal Chemistry
Title: Imaging of P-glycoprotein Function and Expression to Elucidate Mechanisms of Pharmacoresistance in Epilepsy
Volume: 10 Issue: 17
Author(s): Wolfgang Loscher and Oliver Langer
Affiliation:
Keywords: Multidrug transporters, antiepileptic drugs, brain imaging, positron emission tomography, verapamil, tariquidar, P-glycoprotein, Epilepsy, Antiepileptic drugs (AEDs), Erapamil, blood-brain barrier (BBB), CNS disorder, Temporal lobe epilepsy (TLE), Pgp expression, Single photon emission computed tomography (SPECT), Magnetic resonance spectroscopy (MRS), Radiotracers, Pgp substrates, [11C]daunorubicin, [11C]colchicine, [18F]paclitaxel, [11C]carvedilol, [11C]loperamide, [11C]-Ndesmethyl-loperamide, cyclosporin A (CsA), (R)-enantiomer, (S)-enantiomer, Cytochrome P450-mediated metabolism, Pgp function, liquid chromatography tandem mass spectrometry (LC/MS/MS), Chinese hamster ovary resistant cells (CHrB30), [99mTc]sestamibi, Single nucleotide polymorphism (SNP), [11C]phenobarbital, [11C]phenytoin
Abstract: The issue of pharmacoresistance in epilepsy has received considerable attention in recent years, and a number of plausible hypotheses have been proposed. Of these, the so-called transporter hypothesis is the most extensively researched and documented. This hypothesis assumes that refractory epilepsy is associated with a localised over-expression of drug transporter proteins such as P-glycoprotein (Pgp) in the region of the epileptic focus, which actively extrudes antiepileptic drugs (AEDs) from their intended site of action. However, although this hypothesis has biological plausibility, there is no clinical evidence to support the assertion that AEDs are sufficiently strong substrates for transportermediated extrusion from the brain. The use of modern brain imaging techniques to determine Pgp function in patients with refractory epilepsy has started only recently, and may ultimately determine whether increased expression and function of Pgp or other efflux transporters are involved in AED resistance.
Export Options
About this article
Cite this article as:
Loscher Wolfgang and Langer Oliver, Imaging of P-glycoprotein Function and Expression to Elucidate Mechanisms of Pharmacoresistance in Epilepsy, Current Topics in Medicinal Chemistry 2010; 10 (17) . https://dx.doi.org/10.2174/156802610792928095
DOI https://dx.doi.org/10.2174/156802610792928095 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Brain-Derived Neurotrophic Factor and Antidepressant Activity
Current Pharmaceutical Design Phenolic Compounds as Antioxidants: Carbonic Anhydrase Isoenzymes Inhibitors
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: PET and SPECT in Drug Evaluation and Drug Design Imaging Inflammatory Processes, Tumors, and the Endocannabinoid System(Executive Editor: Aren van Waarde)]
Current Pharmaceutical Design Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic Agents
Medicinal Chemistry Myopathic Involvement and Mitochondrial Pathology in Kennedy Disease and in Other Motor Neuron Diseases
Current Molecular Medicine Alzheimer’s Disease, Astrocytes and Kynurenines
Current Alzheimer Research Neurogenesis and Stroke
CNS & Neurological Disorders - Drug Targets Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease
Current Medicinal Chemistry 3D Printing Technology in Pharmaceutical Manufacturing and Drug Delivery Application
Current Pharmaceutical Design Intrahippocampal Amyloid-β (1-40) Injections Injure Medial Septal Neurons in Rats
Current Alzheimer Research Bipolar Affective Disorder, Epilepsy and Migraine – Does Possible Shared Pathogenesis Explain their Association?
Current Psychopharmacology Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration
Coronaviruses Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
MicroRNA Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery Lamotrigine Induced Whole Body Tics: A Case Report and Literature Review
Current Drug Safety The Multiple Aspects of Stroke and Stem Cell Therapy
Current Molecular Medicine Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design <i>In Vitro</i> Antioxidant and Anti-Convulsant Activity of Methanolic Extract of <i>Sarasvata churna</i> Using scPTZ and MES Models
The Natural Products Journal Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature
Current Drug Safety New Avenue of Research: Antiepileptic Drug and Estradiol Neuroprotection in Epilepsy
Recent Patents on CNS Drug Discovery (Discontinued)